Nirupama Devanathan is a Rochester, Minnesota based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Nirupama Devanathan is 34145 for Ophthalmology in Minnesota. Nirupama Devanathan is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Nirupama Devanathan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Female
Practice Address:
200 1st St Sw, Rochester, Minnesota, 55905-0001
Phone:
507-284-2511
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1497502330
NPI Enumeration Date:
30 Apr, 2024
NPI Last Update On:
09 Sep, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Nirupama Devanathan are as mentioned below.
License Number
Specialization
State
Status
34145
Ophthalmology
Minnesota
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
200 1st St Sw, Rochester, Minnesota
Zip:
55905-0001
Phone Number:
507-284-2511
Fax Number:
--
Patients can reach Nirupama Devanathan at 200 1st St Sw, Rochester, Minnesota or can call to book an appointment on 507-284-2511. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.